Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 Jul;60(7):2823–2827. doi: 10.1128/iai.60.7.2823-2827.1992

Construction of a recombinant oral vaccine against Salmonella typhi and Salmonella typhimurium.

Y Cao 1, Z Wen 1, D Lu 1
PMCID: PMC257240  PMID: 1612747

Abstract

The viaB gene coding for the Vi antigen of Salmonella typhi Ty2 was subcloned into expression vector pYA248. The recombinant plasmid was termed SMM202 and transformed into Salmonella typhimurium chi 4072, an attenuated delta cya delta crp mutant. Recombinant S. typimurium Vi4072 had the ability to produce Vi capsular polysaccharide and also to invade and colonize the small intestine, mesenteric lymph nodes, and spleen of BALB/c mice. Mice orally immunized with Vi4072 developed serum and secretory antibody responses to the Vi antigen, as measured by a passive hemagglutination assay. Mice developed a delayed-type hypersensitivity following a footpad injection with Vi antigen after being sensitized orally with a suitable dose of Vi4072. Immunization of mice with Vi4072 afforded complete protection against fatal infection with virulent S. typhi Ty2. All data indicate that this route of antigen delivery is effective for stimulating antibody-mediated immunity and for inducing a cell-mediated immune response in BALB/c mice. Thus, S. typhimurium Vi4072 may serve as a vaccine for protection against typhoid fever and salmonellosis caused by S. typhimurium.

Full text

PDF
2823

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acharya I. L., Lowe C. U., Thapa R., Gurubacharya V. L., Shrestha M. B., Cadoz M., Schulz D., Armand J., Bryla D. A., Trollfors B. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med. 1987 Oct 29;317(18):1101–1104. doi: 10.1056/NEJM198710293171801. [DOI] [PubMed] [Google Scholar]
  2. Ashcroft M. T., Singh B., Nicholson C. C., Ritchie J. M., Sorryan E., Williams F. A seven-year field trial of two typhoid vaccines in Guyana. Lancet. 1967 Nov 18;2(7525):1056–1059. doi: 10.1016/s0140-6736(67)90335-2. [DOI] [PubMed] [Google Scholar]
  3. Baron L. S., Kopecko D. J., McCowen S. M., Snellings N. J., Johnson E. M., Reid W. C., Life C. A. Genetic and molecular studies of the regulation of atypical citrate utilization and variable Vi antigen expression in enteric bacteria. Basic Life Sci. 1982;19:175–194. doi: 10.1007/978-1-4684-4142-0_16. [DOI] [PubMed] [Google Scholar]
  4. CVJETANOVIC B., UEMURA K. THE PRESENT STATUS OF FIELD AND LABORATORY STUDIES OF TYPHOID AND PARATYPHOID VACCINES WITH SPECIAL REFERENCE TO STUDIES SPONSORED BY WORLD HEALTH ORGANIZATION. Bull World Health Organ. 1965;32:29–36. [PMC free article] [PubMed] [Google Scholar]
  5. Collins F. M. Effect of specific immune mouse serum on the growth of Salmonella enteritidis in mice preimmunized with living or ethyl alcohol-killed vaccines. J Bacteriol. 1969 Feb;97(2):676–683. doi: 10.1128/jb.97.2.676-683.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Collins F. M. Vaccines and cell-mediated immunity. Bacteriol Rev. 1974 Dec;38(4):371–402. doi: 10.1128/br.38.4.371-402.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cryz S. J., Jr, Fürer E., Baron L. S., Noon K. F., Rubin F. A., Kopecko D. J. Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a. Infect Immun. 1989 Dec;57(12):3863–3868. doi: 10.1128/iai.57.12.3863-3868.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Curtiss R., 3rd, Goldschmidt R. M., Fletchall N. B., Kelly S. M. Avirulent Salmonella typhimurium delta cya delta crp oral vaccine strains expressing a streptococcal colonization and virulence antigen. Vaccine. 1988 Apr;6(2):155–160. doi: 10.1016/s0264-410x(88)80020-3. [DOI] [PubMed] [Google Scholar]
  9. Curtiss R., 3rd, Kelly S. M. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun. 1987 Dec;55(12):3035–3043. doi: 10.1128/iai.55.12.3035-3043.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eisenstein T. K., Killar L. M., Sultzer B. M. Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. J Infect Dis. 1984 Sep;150(3):425–435. doi: 10.1093/infdis/150.3.425. [DOI] [PubMed] [Google Scholar]
  11. HOBSON D. Resistance to reinfection in experimental mouse typhoid. J Hyg (Lond) 1957 Sep;55(3):334–343. doi: 10.1017/s0022172400037244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hsu H. S. Pathogenesis and immunity in murine salmonellosis. Microbiol Rev. 1989 Dec;53(4):390–409. doi: 10.1128/mr.53.4.390-409.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Klugman K. P., Gilbertson I. T., Koornhof H. J., Robbins J. B., Schneerson R., Schulz D., Cadoz M., Armand J. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet. 1987 Nov 21;2(8569):1165–1169. doi: 10.1016/s0140-6736(87)91316-x. [DOI] [PubMed] [Google Scholar]
  14. Levine M. M., Hone D., Tacket C., Ferreccio C., Cryz S. Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines. Res Microbiol. 1990 Sep-Oct;141(7-8):807–816. doi: 10.1016/0923-2508(90)90114-6. [DOI] [PubMed] [Google Scholar]
  15. Mackaness G. B., Blanden R. V., Collins F. M. Host-parasite relations in mouse typhoid. J Exp Med. 1966 Oct 1;124(4):573–583. doi: 10.1084/jem.124.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nolan C. M., Feeley J. C., White P. C., Jr, Hambie E. A., Brown S. L., Wong K. H. Evaluation of a new assay for Vi antibody in chronic carriers of Salmonella typhi. J Clin Microbiol. 1980 Jul;12(1):22–26. doi: 10.1128/jcm.12.1.22-26.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ou J. T., Baron L. S., Rubin F. A., Kopecko D. J. Specific insertion and deletion of insertion sequence 1-like DNA element causes the reversible expression of the virulence capsular antigen Vi of Citrobacter freundii in Escherichia coli. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4402–4405. doi: 10.1073/pnas.85.12.4402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rockhill R. C., Rumans L. W., Lesmana M., Dennis D. T. Detection of Salmonella typhi D, Vi, and d antigens, by slide coagglutination, in urine from patients with typhoid fever. J Clin Microbiol. 1980 Mar;11(3):213–216. doi: 10.1128/jcm.11.3.213-216.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rubin F. A., Kopecko D. J., Noon K. F., Baron L. S. Development of a DNA probe to detect Salmonella typhi. J Clin Microbiol. 1985 Oct;22(4):600–605. doi: 10.1128/jcm.22.4.600-605.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stabel T. J., Mayfield J. E., Tabatabai L. B., Wannemuehler M. J. Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infect Immun. 1990 Jul;58(7):2048–2055. doi: 10.1128/iai.58.7.2048-2055.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Szu S. C., Stone A. L., Robbins J. D., Schneerson R., Robbins J. B. Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals. J Exp Med. 1987 Nov 1;166(5):1510–1524. doi: 10.1084/jem.166.5.1510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. USHIBA D., SAITO K., AKIYAMA T., NAKANO M., SUGIYAMA T., SHIRONO S. Studies on experimental typhoid: bacterial multiplication and host cell response after infection with Salmonella enteritidis in mice immunized with live and killed vaccines. Jpn J Microbiol. 1959 Apr;3:231–242. doi: 10.1111/j.1348-0421.1959.tb00119.x. [DOI] [PubMed] [Google Scholar]
  23. Wong K. H., Feeley J. C., Northrup R. S., Forlines M. E. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals. Infect Immun. 1974 Feb;9(2):348–353. doi: 10.1128/iai.9.2.348-353.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wong K. H., Pickett M. J., Froman S. Antigens of mycobacterial cell walls. Infect Immun. 1970 Apr;1(4):400–407. doi: 10.1128/iai.1.4.400-407.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES